Abstract
Cardiac positron emission tomography (PET) with generator-produced rubidium-82 (Rb-82) provides information not previously available for optimal diagnosis and management of cardiac disease. This new information includes the accurate, noninvasive diagnosis of coronary artery disease in asymptomatic or symptomatic patients, the noninvasive assessment of coronary stenosis severity, myocardial infarct imaging, myocardial viability, collateral function, and cardiomyopathy. Cardiac positron imaging may be carried out economically at the same or less cost as other high-tech diagnostic imaging but provides perfusion and metabolic information quantitatively for routine clinical studies not available by other diagnostic modalities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
